These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunization against respiratory virus infections. Hobson D Mod Trends Immunol; 1967; 2():53-85. PubMed ID: 4298139 [No Abstract] [Full Text] [Related]
4. Efficacy of a "mixed bacterial vaccine" in prophylaxis of acute respiratory infections: possible role of interferon. Rytel MW; Ferstenfeld JE; Rose HD; Balay J; Pierce WE; Lynch KL Am J Epidemiol; 1974 May; 99(5):347-59. PubMed ID: 4151096 [No Abstract] [Full Text] [Related]
7. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation. Riedl-Seifert RJ; van Aubel A; Kämmereit A; Elsasser U Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900 [No Abstract] [Full Text] [Related]
8. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study. Fumex JP; Michel FB Arzneimittelforschung; 1980; 30(1a):206-13. PubMed ID: 6989376 [No Abstract] [Full Text] [Related]
9. Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology. Charachon R; Lavillauroy PJ; Fumex JP Arzneimittelforschung; 1980; 30(1a):214-20. PubMed ID: 6892781 [No Abstract] [Full Text] [Related]
10. [Use of a polyvalent oral bacterial vaccine in recurrent respiratory infections in children]. Scotti L; Biondelli G; Borzani M Minerva Pediatr; 1987 Apr; 39(7):251-6. PubMed ID: 3614148 [No Abstract] [Full Text] [Related]
11. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts]. Gunchikov MV; Vinnikov AK Vestn Otorinolaringol; 2001; (1):40. PubMed ID: 11247247 [No Abstract] [Full Text] [Related]
12. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial. Rossi S; Tazza R Arzneimittelforschung; 2004; 54(1):50-6. PubMed ID: 14979609 [No Abstract] [Full Text] [Related]
13. Fewer colds with increased vitamin E intake. Burton A Lancet Infect Dis; 2004 Oct; 4(10):600. PubMed ID: 15470764 [No Abstract] [Full Text] [Related]
14. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks. Michel FB; Dussourd d'Hinterland L Arzneimittelforschung; 1980; 30(1a):196-8. PubMed ID: 6892779 [No Abstract] [Full Text] [Related]
15. Salmonella typhosa lipopolysaccharide in chronic bronchitis and prevention of common colds. Chin Med J (Engl); 1976 Mar; 2(2):107-12. PubMed ID: 819228 [No Abstract] [Full Text] [Related]
16. Development of vaccines against common colds. Olszewska W; Zambon M; Openshaw PJ Br Med Bull; 2002; 62():99-111. PubMed ID: 12176853 [TBL] [Abstract][Full Text] [Related]
17. Prevention of infections of the respiratory tract using the oral application of antigens. Tischner H Z Erkr Atmungsorgane; 1991; 176(2-3):131-7. PubMed ID: 1858413 [No Abstract] [Full Text] [Related]
19. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections]. Luther P; Brachmann I; Werchan D; Wittig C; Tischner H Z Erkr Atmungsorgane; 1990; 175(2):95-9. PubMed ID: 2264367 [TBL] [Abstract][Full Text] [Related]
20. [Assessment with clinico-epidemiological method of the effects of antibacterial, polyvalent, oral vaccination, tested on a homogenous category of persons]. Di Raimondo F; Taglieri G; Tocci M Clin Ter; 1971 Oct; 59(1):29-45. PubMed ID: 5157286 [No Abstract] [Full Text] [Related] [Next] [New Search]